Company / Interest Expense
REGENXBIO Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$6.9M
FY2023
5-year range
$771.0K / $23.3M
FY2019-FY2023
Trend
-70.5%
vs FY2022
Sector context
#31 of 44
Health Care
What the data says
At $7M, REGENXBIO Inc.'s interest expense ranks #14 of 44 in the Health Care sector. Increased from $771,000 to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2023 with a 3-year CAGR of +107.2%.
Increased from $771,000 to $7M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +107.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#14 of 44 in Health CareTop 30% of 44This company $6.9M Sector average $291.0M
▼
-97.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +107.2%, indicating consistent growth.
- In FY2023, interest expense decreased 70.5% year-over-year.
- Ranks #31 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $6.9M | -70.5% |
| FY2022 | $23.3M | +2916.1% |
| FY2021 | $771.0K | +0.0% |
| FY2020 | $771.0K | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $321.0K | -47.5% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026